Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNIPHOS ENT vs BRAWN BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNIPHOS ENT BRAWN BIOTECH UNIPHOS ENT/
BRAWN BIOTECH
 
P/E (TTM) x 23.5 -4.8 - View Chart
P/BV x 0.3 1.0 32.7% View Chart
Dividend Yield % 4.9 0.0 -  

Financials

 UNIPHOS ENT   BRAWN BIOTECH
EQUITY SHARE DATA
    UNIPHOS ENT
Mar-23
BRAWN BIOTECH
Mar-23
UNIPHOS ENT/
BRAWN BIOTECH
5-Yr Chart
Click to enlarge
High Rs18423 805.3%   
Low Rs10714 787.1%   
Sales per share (Unadj.) Rs0.274.1 0.3%  
Earnings per share (Unadj.) Rs5.6-2.9 -194.9%  
Cash flow per share (Unadj.) Rs5.7-2.5 -226.3%  
Dividends per share (Unadj.) Rs6.500-  
Avg Dividend yield %4.50-  
Book value per share (Unadj.) Rs431.021.0 2,049.4%  
Shares outstanding (eoy) m69.553.00 2,318.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x687.50.2 279,528.6%   
Avg P/E ratio x25.8-6.3 -409.7%  
P/CF ratio (eoy) x25.4-7.2 -352.7%  
Price / Book Value ratio x0.30.9 39.0%  
Dividend payout %115.20-   
Avg Mkt Cap Rs m10,12155 18,508.9%   
No. of employees `000NANA-   
Total wages/salary Rs m1214 83.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m15222 6.6%  
Other income Rs m4310 478,733.3%   
Total revenues Rs m446222 200.4%   
Gross profit Rs m-29-3 948.0%  
Depreciation Rs m61 553.2%   
Interest Rs m00 0.0%   
Profit before tax Rs m396-4 -9,616.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m45 86.7%   
Profit after tax Rs m392-9 -4,519.0%  
Gross profit margin %-194.5-1.4 14,303.6%  
Effective tax rate %1.0-110.8 -0.9%   
Net profit margin %2,664.8-3.9 -68,238.4%  
BALANCE SHEET DATA
Current assets Rs m532134 396.7%   
Current liabilities Rs m1180 13.1%   
Net working cap to sales %3,539.624.1 14,701.2%  
Current ratio x50.41.7 3,026.1%  
Inventory Days Days713,73810 7,253,010.2%  
Debtors Days Days087,270 0.0%  
Net fixed assets Rs m30,42310 312,994.8%   
Share capital Rs m13930 463.6%   
"Free" reserves Rs m29,83733 90,168.9%   
Net worth Rs m29,97663 47,513.1%   
Long term debt Rs m00-   
Total assets Rs m30,955144 21,539.7%  
Interest coverage x0-44.7-  
Debt to equity ratio x00-  
Sales to assets ratio x01.5 0.0%   
Return on assets %1.3-6.0 -21.2%  
Return on equity %1.3-13.8 -9.5%  
Return on capital %1.3-6.4 -20.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m00-   
Fx outflow Rs m00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m-153 -461.0%  
From Investments Rs m406-1 -42,321.9%  
From Financial Activity Rs m-393NA 491,162.5%  
Net Cashflow Rs m-12 -61.2%  

Share Holding

Indian Promoters % 73.8 53.7 137.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.7 0.6 2,667.8%  
FIIs % 15.7 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 26.2 46.3 56.7%  
Shareholders   12,049 6,139 196.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNIPHOS ENT With:   ADANI ENTERPRISES    REDINGTON    MMTC    SAT INDUSTRIES    LLOYDS ENTERPRISES    


More on UNIPHOS ENT vs BRAWN PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

UNIPHOS ENT vs BRAWN PHARMA Share Price Performance

Period UNIPHOS ENT BRAWN PHARMA
1-Day -0.33% 4.99%
1-Month -5.07% -8.88%
1-Year -7.49% 25.94%
3-Year CAGR 15.92% -2.98%
5-Year CAGR 4.86% -11.53%

* Compound Annual Growth Rate

Here are more details on the UNIPHOS ENT share price and the BRAWN PHARMA share price.

Moving on to shareholding structures...

The promoters of UNIPHOS ENT hold a 73.8% stake in the company. In case of BRAWN PHARMA the stake stands at 53.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of UNIPHOS ENT and the shareholding pattern of BRAWN PHARMA.

Finally, a word on dividends...

In the most recent financial year, UNIPHOS ENT paid a dividend of Rs 6.5 per share. This amounted to a Dividend Payout ratio of 115.2%.

BRAWN PHARMA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of UNIPHOS ENT, and the dividend history of BRAWN PHARMA.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.